Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

HUTCHMED (China) Stock Price, Quotes and Forecasts | NASDAQ:HCM | Benzinga

Q: What sector and industry does HUTCHMED (China) (HCM) operate in?

HUTCHMED (China) is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore HUTCHMED (China) stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HCM.

Open	$16.18
Close	$15.91
Volume / Avg.	82.42K / 80.15K
Day Range	$15.86 - $16.25
52 Wk Range	12.84 - 21.92
Market Cap	$2.82B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	0.39%
Days to Cover	5.47

Recent News

Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million

Hutchmed sells a 45% stake in SHPL for $608 million and focuses on advancing its cancer and immunology pipeline, including clinical trials by 2025.

Vandana Singh

Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Hutchmed scores U.S. success with cancer drug, but profits still dip

Key Takeaways: Hutchmed’s U.S. sales jumped nearly 53% in the second quarter from the previous three months, boosted by uptake of the cancer drug Fruzaqla The company plans to focus on innovative drugs and said it might give up its traditional Chinese medicine business 　 By Molly Wen

The Bamboo Works

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$16.18
Close	$15.91
Volume / Avg.	82.42K / 80.15K
Day Range	$15.86 - $16.25
52 Wk Range	12.84 - 21.92
Market Cap	$2.82B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	0.39%
Days to Cover	5.47

About HUTCHMED (China) Limited

Sector

Health Care

Industry

Pharmaceuticals

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy HUTCHMED (China) (HCM) stock?

You can purchase shares of HUTCHMED (China) (NASDAQ:HCM) through any online brokerage.

View our list of the best stock brokerages

Who are HUTCHMED (China) (HCM) competitors?

Other companies in HUTCHMED (China)’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the forecast, or price target, for HUTCHMED (China) (HCM) stock?

HUTCHMED (China) has a consensus price target of $30.37.

What is the current price for HUTCHMED (China) (HCM)?

The stock price for HUTCHMED (China) (NASDAQ: HCM) is $16.5 last updated February 28, 2025 at 1:17 AM EST.

Does HUTCHMED (China) (HCM) pay a dividend?

There are no upcoming dividends for HUTCHMED (China).

When is HUTCHMED (China) (NASDAQ:HCM) reporting earnings?

HUTCHMED (China)’s FY earnings are confirmed for Wednesday, March 19, 2025.

Is HUTCHMED (China) (HCM) going to split?

There is no upcoming split for HUTCHMED (China).

What sector and industry does HUTCHMED (China) (HCM) operate in?

HUTCHMED (China) is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

HUTCHMED (China) Stock Price, Quotes and Forecasts

HUTCHMED (China) (HCM) Forecast